Resonant Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $639K | Buy |
1,575
+132
| +9% | +$53.6K | 0.04% | 210 |
|
|
2025
Q1 | $719K | Buy |
1,443
+36
| +3% | +$17.9K | 0.05% | 172 |
|
|
2024
Q4 | $733K | Sell |
1,407
-437
| -24% | -$228K | 0.05% | 172 |
|
|
2024
Q3 | $1.14M | Sell |
1,844
-25
| -1% | -$15.5K | 0.08% | 142 |
|
|
2024
Q2 | $1.03M | Buy |
1,869
+227
| +14% | +$126K | 0.08% | 136 |
|
|
2024
Q1 | $955K | Buy |
1,642
+538
| +49% | +$313K | 0.08% | 149 |
|
|
2023
Q4 | $586K | Sell |
1,104
-301
| -21% | -$160K | 0.06% | 173 |
|
|
2023
Q3 | $712K | Buy |
1,405
+464
| +49% | +$235K | 0.08% | 146 |
|
|
2023
Q2 | $491K | Sell |
941
-180
| -16% | -$94K | 0.05% | 170 |
|
|
2023
Q1 | $647K | Sell |
1,121
-135
| -11% | -$77.9K | 0.07% | 152 |
|
|
2022
Q4 | $692K | Buy |
1,256
+114
| +10% | +$62.8K | 0.09% | 139 |
|
|
2022
Q3 | $580K | Buy |
1,142
+12
| +1% | +$6.1K | 0.09% | 137 |
|
|
2022
Q2 | $614K | Buy |
1,130
+101
| +10% | +$54.9K | 0.1% | 132 |
|
|
2022
Q1 | $610K | Buy |
1,029
+45
| +5% | +$26.7K | 0.09% | 128 |
|
|
2021
Q4 | $657K | Sell |
984
-92
| -9% | -$61.4K | 0.1% | 116 |
|
|
2021
Q3 | $615K | Buy |
1,076
+50
| +5% | +$28.6K | 0.11% | 109 |
|
|
2021
Q2 | $518K | Buy |
1,026
+26
| +3% | +$13.1K | 0.1% | 108 |
|
|
2021
Q1 | $457K | Sell |
1,000
-285
| -22% | -$130K | 0.09% | 113 |
|
|
2020
Q4 | $599K | Sell |
1,285
-215
| -14% | -$100K | 0.14% | 96 |
|
|
2020
Q3 | $663K | Sell |
1,500
-23
| -2% | -$10.2K | 0.19% | 86 |
|
|
2020
Q2 | $552K | Sell |
1,523
-460
| -23% | -$167K | 0.16% | 101 |
|
|
2020
Q1 | $562K | Sell |
1,983
-130
| -6% | -$36.8K | 0.2% | 117 |
|
|
2019
Q4 | $686K | Buy |
+2,113
| New | +$686K | 0.22% | 120 |
|